Minnesota SF 1518: Wholesale drug distributor or manufacturer price gouging prohibition; board of pharmacy, commissioner of human services, and health plan companies attorney general notification of prescription drug price increases; attorney general authority to obtain drug pricing information and action authorization; penalties

Status: Referred to Health and Human Services Finance and Policy (as of 2019-02-21)

State: Minnesota · Session: 2019-2020 · Bill: SF 1518

Subjects: Boards, Consumer Protection, Drugs and Medicine, Health and Health Department, Human Services and Human Services Department, Insurance-Health, Legal Proceedings

Sponsors: Klein, Draheim, Jensen, Little, Wiklund

View Minnesota SF 1518 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.